Total Payments
$531.27
2024 Payments
$209.01
Companies
8
Transactions
13
Medicare Patients
6,323
Medicare Billing
$722,880
Payment Breakdown by Category
Food & Beverage$511.27 (96.2%)
Other$20.00 (3.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $511.27 | 12 | 96.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20.00 | 1 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $101.51 | 1 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $94.97 | 1 | $0 (2019) |
| Amgen Inc. | $94.53 | 2 | $0 (2019) |
| Medtronic, Inc. | $87.50 | 1 | $0 (2024) |
| Cook Medical LLC | $52.45 | 1 | $0 (2022) |
| ABBVIE INC. | $47.73 | 3 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $28.94 | 2 | $0 (2022) |
| PFIZER INC. | $23.64 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $209.01 | 3 | GENZYME CORPORATION ($101.51) |
| 2022 | $109.12 | 5 | Cook Medical LLC ($52.45) |
| 2019 | $123.61 | 3 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($94.97) |
| 2018 | $89.53 | 2 | Amgen Inc. ($76.80) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | CREON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $20.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/15/2024 | Medtronic, Inc. | ENDOFLIP (Device) | Food and Beverage | In-kind items and services | $87.50 | General |
| Category: Motility Testing | ||||||
| 02/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $101.51 | General |
| Category: Immunology | ||||||
| 11/24/2022 | Ferring Pharmaceuticals Inc. | CIMZIA (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/13/2022 | Cook Medical LLC | ZENITH ALPHA (Device) | Food and Beverage | Cash or cash equivalent | $52.45 | General |
| Category: Aortic Intervention | ||||||
| 06/20/2022 | Ferring Pharmaceuticals Inc. | CIMZIA (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/18/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: IMMUNOLOGY | ||||||
| 04/07/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: IMMUNOLOGY | ||||||
| 08/28/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $94.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/19/2019 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Cardiology | ||||||
| 02/04/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/16/2018 | Amgen Inc. | Corlanor (Drug) | Food and Beverage | In-kind items and services | $76.80 | General |
| Category: Cardiology | ||||||
| 08/20/2018 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,661 | 1,872 | $1.2M | $188,230 |
| 2022 | 21 | 1,694 | 2,164 | $1.2M | $198,144 |
| 2021 | 19 | 1,622 | 2,040 | $1.2M | $190,582 |
| 2020 | 13 | 1,346 | 1,650 | $956,389 | $145,924 |
Total Patients
6,323
Total Services
7,726
Medicare Billing
$722,880
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 322 | 389 | $135,761 | $40,726 | 30.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 137 | 137 | $259,958 | $30,224 | 11.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 339 | 424 | $99,640 | $29,484 | 29.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 153 | 155 | $247,225 | $14,823 | 6.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 174 | 174 | $61,248 | $14,107 | 23.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 95 | 95 | $41,800 | $12,032 | 28.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 61 | 61 | $103,334 | $11,666 | 11.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 99 | 126 | $28,980 | $8,518 | 29.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 48 | 48 | $21,024 | $5,327 | 25.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 22 | 22 | $37,268 | $3,928 | 10.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 77 | 85 | $12,155 | $3,780 | 31.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 25 | 25 | $42,350 | $3,328 | 7.9% |
| 91065 | Measurement of hydrogen in breath to test for stomach and bowel symptoms | Office | 2023 | 25 | 41 | $10,638 | $2,830 | 26.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 22 | 27 | $8,964 | $2,639 | 29.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 22 | 22 | $39,930 | $2,537 | 6.4% |
| 76981 | Ultrasound scan of organ tissue for measuring elasticity | Office | 2023 | 13 | 13 | $4,725 | $1,224 | 25.9% |
| 43450 | Dilation of esophagus | Facility | 2023 | 16 | 16 | $20,000 | $549.28 | 2.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 12 | $1,488 | $507.84 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 432 | 612 | $143,820 | $43,907 | 30.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 120 | 120 | $227,700 | $24,516 | 10.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 195 | 233 | $81,317 | $23,603 | 29.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 175 | 176 | $280,720 | $18,581 | 6.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 200 | 200 | $70,400 | $17,237 | 24.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 68 | 68 | $29,920 | $9,108 | 30.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 123 | 147 | $33,810 | $8,938 | 26.4% |
About Dr. Omar Tamimi, M.D
Dr. Omar Tamimi, M.D is a Gastroenterology healthcare provider based in Toms River, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932148327.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Omar Tamimi, M.D has received a total of $531.27 in payments from pharmaceutical and medical device companies, with $209.01 received in 2024. These payments were reported across 13 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($511.27).
As a Medicare-enrolled provider, Tamimi has provided services to 6,323 Medicare beneficiaries, totaling 7,726 services with total Medicare billing of $722,880. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Toms River, NJ
- Active Since 06/04/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1932148327
Products in Payments
- DUPIXENT (Biological) $101.51
- XIFAXAN (Drug) $94.97
- Corlanor (Drug) $94.53
- ENDOFLIP (Device) $87.50
- ZENITH ALPHA (Device) $52.45
- CIMZIA (Drug) $28.94
- RINVOQ (Biological) $27.73
- XELJANZ (Drug) $23.64
- CREON (Drug) $20.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Toms River
Mr. Neil Nagaria, Md, MD
Gastroenterology — Payments: $18,349
Gastroenterology $18,349
Teresa Tacopina, Md, MD
Gastroenterology — Payments: $7,735
Gastroenterology $7,735
Dr. Eric Eschinger, Md, MD
Gastroenterology — Payments: $6,236
Gastroenterology $6,236
Kenneth Glazier
Gastroenterology — Payments: $5,912
Gastroenterology $5,912
Carl Raso, Md, MD
Gastroenterology — Payments: $5,227
Gastroenterology $5,227
Gabrielle Corpuz, Pa-C, PA-C
Gastroenterology — Payments: $4,258
Gastroenterology $4,258